Patient-Powered Research and Community
Since 2017, the Rare Cancer Research Foundation (RCRF) has helped patients donate their tissue directly to researchers from over 120 hospitals, resulting in 65+ research models for rare cancers that have already provided countless research opportunities, scientific discoveries, and urgent hope.
Our patient-powered platform aims to fundamentally change how patients can advocate for their care while empowering the development of effective treatments through the donation of tissue samples and data for research.
Tissue Donation
Donating tissue samples is the most effective way patients can help researchers make medical breakthroughs and advance the development of new treatments. We coordinate the safe transportation of live tissue, post-surgery, to research projects or our biobank.
Biobank
Stored tissue has great value for researchers and for patients themselves. The Pattern.org Biobank is a shared resource across the rare cancer community, bringing together tissue from across institutions and rare cancer types to create a powerful engine for research and discovery.
Powerful Tools and Resources
COMING SOON. Building tools for all rare cancer patients to access more information about their cancer and treatment options including
An online portal for sharing your data and history with clinicians and researchers
Disease-specific resources including open clinical trials, literature searches, and specialists
Genomic sequencing for every Pattern.org patient to support patients finding more targeted treatment options
120+
Partner Institutions within the USA
95%
Tissue Collection Success Rate
65+
Rare Cancer Models Developed
Our Work
Over 500,000 people every year are diagnosed with rare cancer, yet most rare cancers do not have effective treatments.
Led by a team of multidisciplinary scientists, cancer patients, and clinicians, our work is guided by the experiences, needs, and voices of those with rare cancer and the researchers whose mission it is to one day find a cure for these diseases.
We are building the tools and infrastructure that empower patients to advocate for their care while directly impacting cancer research.